Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AL58805 |
| Trade Name | |
| Synonyms | AL 58805|AL-58805 |
| Drug Descriptions |
Limited information is currently available on AL58805, a putative dual-target PI3K/mTOR inhibitor (Sep 2026). |
| DrugClasses | mTOR Inhibitor 52 PI3K Inhibitor (Pan) 44 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AL58805 | AL58805 | 0 | 0 |
| AL58805 + AL8326 | AL58805 AL8326 | 0 | 1 |
| AL58805 + Anlotinib | AL58805 Anlotinib | 0 | 1 |
| AL58805 + Eribulin | AL58805 Eribulin | 0 | 1 |
| AL58805 + Fulvestrant | AL58805 Fulvestrant | 0 | 1 |
| AL58805 + Lomustine + Temozolomide | AL58805 Lomustine Temozolomide | 0 | 1 |